Cohance Life
Sector : Healthcare | Industry : Pharmaceuticals & Drugs
* BSE Market Depth ()
| BUY | SELL | ||
|---|---|---|---|
| QTY | PRICE | PRICE | QTY |
| Total | Total | ||
Cohance Life Quarterly Earnings
Cohance Life quarterly & annual earnings - Track stocks financial health, Earnings performance, key metrics like revenue, net profit, and growth trends. Compare stock's quarter on quarter metrics such as revenue, net income, operating margin, and earnings per share (EPS).
More insights like Forecast, Peer comparison, latest earnings transcripts & corporate action will help to overall analyse the stock's performance . Explore trends, track growth, and gain a deeper understanding of the company's strategy and market position with every quarterly release.
Read More[+]- Financial Performance
- Results
- Forecast
- Peer Comparison
Financial Performance
| Quarter | Net Profit | YoY Change% |
|---|---|---|
| No best quarters data | ||
| Quarter | Net Profit | YoY Change% |
|---|---|---|
| No worst quarter data | ||
Earnings Forecast PRO
Earnings reviewPro Exclusive
- Earnings Transcript
- Investor Presentations
Corporate action
- Announcements
- Board Meetings
- Bonus
- More
Frequently Asked Questions
What is the Latest Results for Cohance Lifesciences Ltd.
What is the net profit reported by Cohance Lifesciences Ltd. in Q1 FY25-26
Cohance Lifesciences Ltd. reported a net profit of Rs 46.
What is the Revenue Earned by Cohance Lifesciences Ltd.?
Cohance Lifesciences Ltd. reported a revenue earned of Rs 549.
What is the dividend declared in the current financial year?
Cohance Lifesciences Ltd. has declared a dividend of Rs 1.00 on 09 Sep, 2022.
What was the last bonus declared by Cohance Lifesciences Ltd.
The last bonus declared by Cohance Lifesciences Ltd. was on 17 Aug, 2020.
What is the reported EPS & estimated EPS for Cohance Lifesciences Ltd.
The reported EPS for Cohance Lifesciences Ltd. is 6.69 and the estimated EPS is --.
What is the Latest Results for Cohance Lifesciences Ltd.
What is the net profit reported by Cohance Lifesciences Ltd. in Q1 FY25-26
Cohance Lifesciences Ltd. reported a net profit of Rs 46.
What is the Revenue Earned by Cohance Lifesciences Ltd.?
Cohance Lifesciences Ltd. reported a revenue earned of Rs 549.
What is the dividend declared in the current financial year?
Cohance Lifesciences Ltd. has declared a dividend of Rs 1.00 on 09 Sep, 2022.
What was the last bonus declared by Cohance Lifesciences Ltd.
The last bonus declared by Cohance Lifesciences Ltd. was on 17 Aug, 2020.
What is the reported EPS & estimated EPS for Cohance Lifesciences Ltd.
The reported EPS for Cohance Lifesciences Ltd. is 6.69 and the estimated EPS is --.